Want to see CCM full AI Analyst Report?
Concord Medical Services (CCM) Stock Statistics & Valuation Metrics
Total Valuation
Concord Medical Services has a market cap or net worth of $15.59M. The enterprise value is $3342.59T.
- Market Cap
- $15.59M
- Enterprise Value
- $3342.59T
Share Statistics
Concord Medical Services has 2,815,458 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,815,458
- Owned by Insiders
- ―
- Owned by Institutions
- 0.49%
Financial Efficiency
Concord Medical Services’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is -4.26%.
- Return on Equity (ROE)
- 0.04
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- -4.26%
- Return on Capital Employed (ROCE)
- -0.05
- Revenue Per Employee
- 754.94K
- Profits Per Employee
- -152.15K
- Employee Count
- 610
- Asset Turnover
- 0.07
- Inventory Turnover
- 9.46
Valuation Ratios
The current PE Ratio of Concord Medical Services is -0.03. Concord Medical Services’s PEG ratio is -0.00.
- PE Ratio
- -0.03
- PS Ratio
- 0.01
- PB Ratio
- -0.00
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Concord Medical Services had revenue of 460.51M and earned -92.81M in profits. Earnings per share was -621.00.
- Revenue
- 460.51M
- Gross Profit
- 25.82M
- Operating Income
- -239.33M
- Pretax Income
- -373.36M
- Net Income
- -92.81M
- EBITDA
- -71.77M
- Earnings Per Share (EPS)
- -621.00
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Concord Medical Services pays an annual dividend of $0.99, resulting in a dividend yield of ―
- Dividend Per Share
- $0.99
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -3094.32%
Stock Price Statistics
- Beta
- 0.75
- 52-Week Price Change
- -30.00%
- 50-Day Moving Average
- 3.90
- 200-Day Moving Average
- 4.21
- Relative Strength Index (RSI)
- 52.49
- Average Volume (3m)
- 45.27K
Important Dates
Concord Medical Services upcoming earnings date is ―, Before Open (Confirmed).
- Last Earnings Date
- Sep 26, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- Dec 23, 2015
Financial Position
Concord Medical Services as a current ratio of 0.48, with Debt / Equity ratio of -172.84%
- Current Ratio
- 0.48
- Quick Ratio
- 0.46
- Debt to Market Cap
- 882.00
- Net Debt to EBITDA
- -46.50
- Interest Coverage Ratio
- -1.57
Taxes
In the past 12 months, Concord Medical Services has paid 6.06M in taxes.
- Income Tax
- 6.06M
- Effective Tax Rate
- -0.02
Enterprise Valuation
Concord Medical Services EV to EBITDA ratio is -98.85, with an EV/FCF ratio of 0.00.
- EV to Sales
- 6.88
- EV to EBITDA
- -98.85
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Concord Medical Services has $297.79M in cash and marketable securities with $3.63B in debt, giving a net cash position of -$3.34B billion.
- Cash & Marketable Securities
- $297.79M
- Total Debt
- $3.63B
- Net Cash
- -$3.34B
- Net Cash Per Share
- -$1,185.32
- Tangible Book Value Per Share
- $4,445.60
Margins
Gross margin is 8.75%, with operating margin of -34.41%, and net profit margin of -22.84%.
- Gross Margin
- 8.75%
- Operating Margin
- -34.41%
- Pretax Margin
- -57.81%
- Net Profit Margin
- -22.84%
- EBITDA Margin
- -6.96%
- EBIT Margin
- -43.80%
Analyst Forecast
The average price target for Concord Medical Services is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 20.26%
- EPS Growth Forecast
- 69.68%
Scores
- Smart Score
- ―
- AI Score
- 40
